CRISPR Therapeutics proved the strength of its technology a couple of years ago when it won approval for its first product.
Intellia Therapeutics, a leading biotechnology company, announced that its CRISPR-based treatment for a rare swelling ...
Charles Gersbach and his colleagues are pursuing promising CRISPR technologies focused on controlling gene activity rather ...
CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the first quarter ended March 31, 2026. “The first ...
Hosted on MSN
CRISPR breakthroughs shaping next-gen medicine
From cancer-targeting enzymes to AI-designed editors, CRISPR technology is rapidly evolving into safer, more precise tools for research and therapy. Innovations like ThermoCas9, chromosome silencing ...
JMIR Publications today featured two new stories in its News and Perspectives section, highlighting a shift toward proactive, ...
Scribe Therapeutics to highlight engineered CRISPR platform advances and lead cardiometabolic pipeline at ASGCT and EAS Congress 2026 ...
A recent review published in the journal Engineering delves into the significant advancements and potential of CRISPR technologies in the field of regenerative medicine. The study, authored by ...
A recent review published in the journal Engineering delves into the significant advancements and potential of CRISPR technologies in the field of regenerative medicine. The study, authored by ...
Researchers have used modified CRISPR to silence the extra chromosome 21 in Down syndrome cells, showing promising ...
DUBLIN--(BUSINESS WIRE)--The "CRISPR Technology Market" report has been added to ResearchAndMarkets.com's offering. The CRISPR Technology Market was valued at USD 2024 in 2029, and is expected to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results